Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells

E. Giovannetti, C. Lemos, C. Tekle, K Smid, S. Nannizzi, J.A. Rodriguez, S. Ricciardi, R. Danesi, G. Giaccone, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1290-1300
JournalMolecular Pharmacology
Issue number4
Publication statusPublished - 2008

Cite this